Pulnovo Medical, a pioneer in breakthrough therapies for treating Pulmonary Hypertension and Heart Failure, today announced the successful completion of an oversubscribed $100 million strategic ...

For the roughly 6 million Americans living with atrial fibrillation, catheter ablation has become an increasingly common ...

Tectonic Therapeutic is reviving relaxin biology with TX45, targeting Group 2 Pulmonary Hypertension with HFpEF. Check out ...

RAPIBLYK (R) is an ultra-short-acting, selective beta-1 adrenergic receptor blocker administered intravenously in a monitored hospital setting. Its pharmacological profile allows for rapid onset and ...

Allrock Bio has dosed the first participants in a small clinical trial testing ROC-101 as an add-on treatment for pulmonary ...

Cautionary Language Concerning Forward-Looking Statements ...

(Alliance News) - GSK PLC on Wednesday said it has completed the acquisition of Canada-based clinical stage biopharmaceutical ...

Three cancer drugs and a new eczema medication are among the pharmaceuticals that a medical body has accepted for use by NHS Scotland.

Positive airway pressure therapy is linked with reduced pulmonary arterial pressures in patients with severe obstructive sleep apnea or obesity hypoventilation syndrome.

Now that her health has improved, columnist Jolie Lizana's greatest challenge is learning how to live fully within the limits ...